Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Parsons

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
American Journal of Obstetrics and Gynecology|June 18, 2010
Assessment of the alveolar-arterial oxygen gradient as a screening test for pulmonary embolism in pregnancyAaron B Deutsch, Pamela Twitty, Katheryne Downes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2020
Considerations in assessing germline variant pathogenicity using cosegregation analysisSophie Belman, Michael T Parsons, Amanda B Spurdle, et al.
Journal of Medical Genetics|February 28, 2012
Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classificationMichael T Parsons, Daniel D Buchanan, Bryony Thompson, et al.
Journal of Medical Genetics|December 30, 2023
Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for <i>BRCA1/2</i>Giovanni Innella, Simona Ferrari, Sara Miccoli, et al.
Cancers|January 31, 2019
GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 GenesLaura Caleca, Mara Colombo, Thomas van Overeem Hansen, et al.
Bioinformatics (Oxford, England)|April 6, 2023
SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletionDaffodil M Canson, Aimee L Davidson, Miguel de la Hoya, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variantsOlga Kondrashova, Rebecca L Johnston, Michael T Parsons, et al.
Breast Cancer Research and Treatment|October 28, 2020
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patientsVanessa Lattimore, Michael T Parsons, Amanda B Spurdle, et al.
Human Mutation|February 18, 2021
Considerations for using population frequency data in germline variant interpretation: Cancer syndrome genes as a modelAimee L Davidson, Conrad Leonard, Lambros T Koufariotis, et al.
Epigenetics|January 5, 2016
DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancerKirsty J Flower, Natalie S Shenker, Mona El-Bahrawy, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
American Journal of Obstetrics and Gynecology|June 18, 2010
Assessment of the alveolar-arterial oxygen gradient as a screening test for pulmonary embolism in pregnancyAaron B Deutsch, Pamela Twitty, Katheryne Downes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 11, 2020
Considerations in assessing germline variant pathogenicity using cosegregation analysisSophie Belman, Michael T Parsons, Amanda B Spurdle, et al.
Journal of Medical Genetics|February 28, 2012
Correlation of tumour BRAF mutations and MLH1 methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classificationMichael T Parsons, Daniel D Buchanan, Bryony Thompson, et al.
Journal of Medical Genetics|December 30, 2023
Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for <i>BRCA1/2</i>Giovanni Innella, Simona Ferrari, Sara Miccoli, et al.
Cancers|January 31, 2019
GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 GenesLaura Caleca, Mara Colombo, Thomas van Overeem Hansen, et al.
Bioinformatics (Oxford, England)|April 6, 2023
SpliceAI-10k calculator for the prediction of pseudoexonization, intron retention, and exon deletionDaffodil M Canson, Aimee L Davidson, Miguel de la Hoya, et al.
Medrxiv : the Preprint Server for Health Sciences|March 23, 2026
Cancer genomic profiling predicts pathogenicity of BRCA1 and BRCA2 variantsOlga Kondrashova, Rebecca L Johnston, Michael T Parsons, et al.
Breast Cancer Research and Treatment|October 28, 2020
Under-ascertainment of breast cancer susceptibility gene carriers in a cohort of New Zealand female breast cancer patientsVanessa Lattimore, Michael T Parsons, Amanda B Spurdle, et al.
Human Mutation|February 18, 2021
Considerations for using population frequency data in germline variant interpretation: Cancer syndrome genes as a modelAimee L Davidson, Conrad Leonard, Lambros T Koufariotis, et al.
Epigenetics|January 5, 2016
DNA methylation profiling to assess pathogenicity of BRCA1 unclassified variants in breast cancerKirsty J Flower, Natalie S Shenker, Mona El-Bahrawy, et al.
Pageof 9